D

DURECT Corp
D

DRRX

0.70000
USD
0.09
(13.88%)
مغلق
حجم التداول
773
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
21,729,387
أصول ذات صلة
A
ALDX
0.03000
(1.40%)
2.18000 USD
A
AQST
0.04000
(1.45%)
2.79000 USD
A
AXSM
-0.610
(-0.56%)
108.150 USD
B
BHC
-0.14000
(-2.98%)
4.56500 USD
B
BNTC
0.160
(1.17%)
13.880 USD
CAH
CAH
0.940
(0.64%)
148.180 USD
المزيد
الأخبار المقالات

العنوان: DURECT Corp

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entitiesand proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.